A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation

Bakirkoy Dr. Sadi Konuk Training and Research Hospital

Status

Completed

Conditions

COVID-19 Pneumonia

Treatments

Procedure: Internal jugular vein cannulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04954118

2020-287

Details and patient eligibility

About

During the COVID-19 pandemic, health employees are at high risk of infection. This study aimed to determine experiences with an aerosol box (AB), used with the aim of preventing contamination by droplets during internal jugular vein cannulation which requires close contact with COVID-19 patients, and the necessity to use this device.

Full description

The study included 40 patients with diagnosis of COVID-19 requiring central venous catheter during treatment in the ward. The patients were randomly allocated to one of the two protective equipment groups and, then, randomly assigned to one of the five clinicians. Group P&A had both personal protective equipment (PPE) and AB used, while Group P included patients where PPE was used alone. Clinicians completed a survey after performing the procedure to evaluate the use of the aerosol box. Collected data of the procedures and patients, were analyzed. In addition, survey data were evaluated.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients diagnosed with COVID-19 and inserted central venous catheter while being treated in the ward

Exclusion criteria

Patients under the age of 18 years
Patients who can not lie in the supine position due to severe respiratory distress,
Patients with thrombus in the right İJV in evaluation with US